Propanc Biopharma closes $40K convertible note with investor

Propanc Biopharma, Inc.

Closed sale of $40K convertible promissory note to an investor on Oct 29, 2023.
Note is convertible into common shares at investor's option after 180 days from issuance.
Funds were received and transaction closed on Oct 29; initially disclosed on Oct 26, 2023.
Proceeds likely for general working capital; no other material terms changed from prior disclosure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.